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Background 
 
• The striatum is a subnucleus of the basal ganglia with the primary cell 
population consisting of Medium Spiny Neurons (MSNs)4  
• Abnormal striatal functioning has been linked to ailments including 
Parkinson’s disease, Huntington’s disease, and addiction1,2,8  
• MSNs receive both dopamine and glutamate innervation from the cortex and 
midbrain respectively6,7 
• The prevailing model of MSNs shows them as expressing either D1 or D2 
dopamine receptors5 
• D1 pathway – Gs ; Activates adenylyl cyclase 
• D2 pathway – Gi ; Blocks adenylyl cyclase 
Results 
Conclusions  
 
• Our results indicate that there is likely a dopamine and Gq receptor mediated 
mechanism that is responsible for the arborization of MSNs in development  
• Dopamine present in cultures increases arborization between 13 and 19 div 
• The presence of D1 and D2 receptor agonists fails to mimic the increased distal 
arborization seen in the presence of dopamine  
• Inhibition of PLC blocked the developmental effects observed with the presence of 
dopamine  
• MSNs transfected with a designer Gq receptor showed developmental effects 
similar to that of dopamine treated cells 
 
 
Future Directions: 
• Test MSN cell cultures on the possible role of a D1-D2 receptor heter0dimer  
• D1-D2 homodimers work through a Gq-dopamine mediated mechanism, similar to 
the results we’ve obtained 
• The drug SKF83959 has shown D1-D2 receptor specificity at concentrations lower 
than 100uM 
• Test whether the developmental affects seen in cultures treated with dopamine are 
directly affecting MSNs or indirectly acting through cortical neurons 
 
 
 
Hypothesis 
• If MSN treatment with a dopamine D1 and D2 receptor agonists fails to 
replicate the dendrite growth observed when cells are cultured with 
dopamine, then dopamine is likely acting through a different mechanism 
• The activation of a transfected Gq pathway will mimic results of cells 
cultured in the presence of dopamine  
• MSNs treated with the D1-D2 receptor agonist SKF83959 will mirror 
results gained from transfected Gq treatment and cells cultured with 
dopamine  
Abstract  
 
There exists considerable evidence linking the role of dopamine receptor activation of 
Medium Spiny Neurons (MSNs) in the striatum to neurite development. A better 
understanding of this link between receptor activation and dendrite growth and 
plasticity can significantly contribute towards the understanding of ailments including 
Huntington’s disease, depression, and addiction. MSNs cultured in the presence of 
dopamine (+DA) show significant dendrite growth and arborization compared to 
controls. Interestingly, cultures treated with dopamine stimulatory (D1) and dopamine 
inhibitor (D2) specific receptor agonists show little to no change in dendrite 
development compared to -DA controls. These results implicate an alternative 
dopamine mechanism separate from that of the traditional D1 and D2 pathways. 
Previous work has shown that the use of a Gq coupled Designer Receptor Exclusively 
Activated by Designer Drugs (DREADD), selectively activated by clozapine-n-oxide 
(CNO), exhibits dendrite growth similar to that observed in +DA MSNs. In our current 
study, we tested the potential role of a Gq coupled dopamine receptor in MSN 
development using the D1-D2 selective agonist SKF83959. 
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Methods 
The striatum and cortex were 
removed from E15-16 mice and 
combined at a 3 cortex : 2 striatum 
ratio in culture  
 
Cell cultures were treated under the 
following conditions: 
• DA- 
• DA+ 
• SKF83959 
• Gq DREADD +CNO 
• Gq DREADD +DA 
 
After 19 days, cultures were fixed, 
permeabilized, and immunostained 
for DARPP32, DAPI and Gq DREADD 
receptors  
DARPP32 positive neurons were 
imaged using a Zeiss Axiovert M200 
fluorescent microscope and Micro-
Manager software 
Imaged MSNs were traced using  a 
ImageJ (NIH) FIJI plugin and analyzed 
with a Sholl analysis  
Selected culture suspensions were 
transfected with Gq DREADD via 
electroporation 
Figure 1: Most dendrite arborization occurred 
between 13-19 div and peaked around ring 
number 5 and 6 (50-60um from the soma). For 
19 div cultures treated with dopamine (+DA), 
there was a significant increase in ring crossings, 
signifying increased arborization3. 
 
Figure 2: MSNs cultured with D1 receptor agonist 
(SKF) and/or D2 receptor agonist (quinprole) 
failed to replicate the increase in arborization 
observed in cultures treated with dopamine3. 
Suggesting that dopamine is acting via a non-
traditional pathway. 
 
Figure 3: The effects of dopamine on dendritic 
arborization in MSN cell cultures was significantly 
decreased in the presence of the phospholipase-C 
antagonist U731223. This suggests the role of a Gq 
pathway. 
 
 
Figure 4: When MSNs were transfected with a 
designer Gq receptor specifically activated by CNO 
(DREADDs), there was a significant increase in 
dendrite arborization that was comparable to cells 
that received dopamine treatment. These cells 
also had significantly greater arborization than 
cells not exposed to dopamine9.  
